| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Operating expenses | ||||||
Research and development | ||||||
34,319 | 31,749 | 12,384 | ||||
General and administrative | ||||||
9,952 | 4,668 | 2,054 | ||||
Total operating expenses | ||||||
44,271 | 36,417 | 14,438 | ||||
Loss from operations | ||||||
-44,271 | -36,417 | -14,438 | ||||
Interest income | ||||||
2,288 | 1,994 | 150 | ||||
Other income (expense), net | ||||||
8 | 77 | 2,426 | ||||
Net loss | ||||||
-41,975 | -34,346 | -11,862 | ||||
Change in unrealized (losses) gains on marketable securities | ||||||
96 | -30 | -1 | ||||
Comprehensive loss | ||||||
-41,879 | -34,376 | -11,863 | ||||
Net loss per common share, basic and diluted | ||||||
-3.36 | -35.92 | -17.06 | ||||
Weighted average number of common shares outstanding used in computing net loss per share, basic and diluted | ||||||
12,496 | 956 | 695 | ||||